Blanc, Eric
Holtgrewe, Manuel
Dhamodaran, Arunraj
Messerschmidt, Clemens
Willimsky, Gerald
Blankenstein, Thomas
Beule, Dieter
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB-TR36)
Deutsche Forschungsgemeinschaft (SFB-TR36)
Deutsche Krebshilfe (111546)
Deutsche Krebshilfe (111546)
Berlin Institute of Health (CRG-1)
Berlin Institute of Health (CRG-1)
Article History
Received: 9 April 2019
Accepted: 25 October 2019
First Online: 27 November 2019
Ethics approval and consent to participate
: All animal experiments were performed according to institutional and national guidelines and regulations. The experiments were approved by the governmental authority (Landesamt für Gesundheit und Soziales, Berlin).
: Not applicable
: The authors declare the following competing interests: in 2013, the Max-Delbrück Center (MDC) (T.B. & G.W.) has filed a patent on mutation-specific TCRs (US20150307585A1).